Is macrocytosis a potential biomarker of the efficacy of dose-dense paclitaxel–carboplatin combination therapy in patients with epithelial ovarian cancer?
Boraska Jelavić, Tihana, Boban, Toni, Brčić, Luka, Vrdoljak, EduardLanguage:
english
Journal:
Anti-Cancer Drugs
DOI:
10.1097/cad.0000000000000538
Date:
July, 2017
File:
PDF, 195 KB
english, 2017